Is Amazon an AI Stock?
With the market starting to look skittish on pure-play AI…
Sell
24
NMTC Quote, Financials, Valuation and Earnings
Last price:
$0.68
Seasonality move
:
-4.53%
Day range:
$0.67 - $0.72
52-week range:
$0.40 - $1.39
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
2.45x
P/B ratio:
4.10x
Volume:
71.4K
Avg. volume:
152.3K
1-year change:
5.06%
Market cap:
$33.5M
Revenue:
$3.5M
EPS (TTM):
-$0.15
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
NMTC
NeuroOne Medical Technologies Corp.
|
$2.5M | -- | -57.12% | -57.14% | $2.23 |
|
IVF
INVO Fertility, Inc.
|
$1.8M | -- | -8.8% | -- | -- |
|
NTRB
Nutriband, Inc.
|
$675K | -$0.17 | 4.52% | -54.85% | $15.00 |
|
NVNO
enVVeno Medical Corp.
|
-- | -$0.28 | -- | -9.68% | $12.50 |
|
PAHC
Phibro Animal Health Corp.
|
$345.4M | $0.60 | 15% | 756.68% | $43.00 |
|
SINT
SINTX Technologies, Inc.
|
$200K | -$0.55 | -74.97% | -92.1% | $16.75 |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
NMTC
NeuroOne Medical Technologies Corp.
|
$0.67 | $2.23 | $33.5M | -- | $0.00 | 0% | 2.45x |
|
IVF
INVO Fertility, Inc.
|
$1.64 | -- | $24.8M | -- | $0.00 | 0% | 0.03x |
|
NTRB
Nutriband, Inc.
|
$5.06 | $15.00 | $60.8M | -- | $0.00 | 0% | 21.85x |
|
NVNO
enVVeno Medical Corp.
|
$0.39 | $12.50 | $7.8M | -- | $0.00 | 0% | 473.07x |
|
PAHC
Phibro Animal Health Corp.
|
$40.77 | $43.00 | $1.7B | 24.51x | $0.12 | 1.18% | 1.19x |
|
SINT
SINTX Technologies, Inc.
|
$3.84 | $16.75 | $14.8M | -- | $0.00 | 0% | 6.51x |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
NMTC
NeuroOne Medical Technologies Corp.
|
3.49% | 2.039 | 0.87% | 5.64x |
|
IVF
INVO Fertility, Inc.
|
41.99% | -0.446 | 10.12% | 0.07x |
|
NTRB
Nutriband, Inc.
|
3.08% | 2.796 | 0.31% | 4.55x |
|
NVNO
enVVeno Medical Corp.
|
2.62% | 2.197 | 4.32% | 12.90x |
|
PAHC
Phibro Animal Health Corp.
|
71.58% | 2.736 | 47.87% | 1.12x |
|
SINT
SINTX Technologies, Inc.
|
45.47% | 1.079 | 22.94% | 1.47x |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
NMTC
NeuroOne Medical Technologies Corp.
|
$914.8K | -$1.9M | -151.86% | -166.02% | -111.24% | -$1.5M |
|
IVF
INVO Fertility, Inc.
|
$492.6K | -$1.6M | -188.23% | -471.28% | -93.08% | -$1.8M |
|
NTRB
Nutriband, Inc.
|
$156.9K | -$2M | -114.42% | -117.44% | -321.8% | -$1.3M |
|
NVNO
enVVeno Medical Corp.
|
-$120K | -$4.9M | -56.26% | -57.7% | -- | -$4.4M |
|
PAHC
Phibro Animal Health Corp.
|
$119.3M | $47.9M | 6.8% | 24.77% | 13.16% | -$4.5M |
|
SINT
SINTX Technologies, Inc.
|
-$66K | -$3.4M | -115.95% | -208.36% | -1612.98% | -$2.6M |
NeuroOne Medical Technologies Corp. vs. Competitors
-
Which has Higher Returns NMTC or IVF?
INVO Fertility, Inc. has a net margin of -88.5% compared to NeuroOne Medical Technologies Corp.'s net margin of -150.51%. NeuroOne Medical Technologies Corp.'s return on equity of -166.02% beat INVO Fertility, Inc.'s return on equity of -471.28%.
Company Gross Margin Earnings Per Share Invested Capital NMTCNeuroOne Medical Technologies Corp.53.94% -$0.03 $8.5M IVFINVO Fertility, Inc.28.04% -$6.14 $10.1M -
What do Analysts Say About NMTC or IVF?
NeuroOne Medical Technologies Corp. has a consensus price target of $2.23, signalling upside risk potential of 231.6%. On the other hand INVO Fertility, Inc. has an analysts' consensus of -- which suggests that it could grow by 8680.49%. Given that INVO Fertility, Inc. has higher upside potential than NeuroOne Medical Technologies Corp., analysts believe INVO Fertility, Inc. is more attractive than NeuroOne Medical Technologies Corp..
Company Buy Ratings Hold Ratings Sell Ratings NMTCNeuroOne Medical Technologies Corp.1 0 0 IVFINVO Fertility, Inc.0 0 0 -
Is NMTC or IVF More Risky?
NeuroOne Medical Technologies Corp. has a beta of 0.703, which suggesting that the stock is 29.673% less volatile than S&P 500. In comparison INVO Fertility, Inc. has a beta of 2.540, suggesting its more volatile than the S&P 500 by 153.97%.
-
Which is a Better Dividend Stock NMTC or IVF?
NeuroOne Medical Technologies Corp. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. INVO Fertility, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. NeuroOne Medical Technologies Corp. pays -- of its earnings as a dividend. INVO Fertility, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios NMTC or IVF?
NeuroOne Medical Technologies Corp. quarterly revenues are $1.7M, which are smaller than INVO Fertility, Inc. quarterly revenues of $1.8M. NeuroOne Medical Technologies Corp.'s net income of -$1.5M is higher than INVO Fertility, Inc.'s net income of -$2.6M. Notably, NeuroOne Medical Technologies Corp.'s price-to-earnings ratio is -- while INVO Fertility, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for NeuroOne Medical Technologies Corp. is 2.45x versus 0.03x for INVO Fertility, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income NMTCNeuroOne Medical Technologies Corp.2.45x -- $1.7M -$1.5M IVFINVO Fertility, Inc.0.03x -- $1.8M -$2.6M
-
Which has Higher Returns NMTC or NTRB?
Nutriband, Inc. has a net margin of -88.5% compared to NeuroOne Medical Technologies Corp.'s net margin of -321.33%. NeuroOne Medical Technologies Corp.'s return on equity of -166.02% beat Nutriband, Inc.'s return on equity of -117.44%.
Company Gross Margin Earnings Per Share Invested Capital NMTCNeuroOne Medical Technologies Corp.53.94% -$0.03 $8.5M NTRBNutriband, Inc.25.21% -$2.12 $8.8M -
What do Analysts Say About NMTC or NTRB?
NeuroOne Medical Technologies Corp. has a consensus price target of $2.23, signalling upside risk potential of 231.6%. On the other hand Nutriband, Inc. has an analysts' consensus of $15.00 which suggests that it could grow by 196.44%. Given that NeuroOne Medical Technologies Corp. has higher upside potential than Nutriband, Inc., analysts believe NeuroOne Medical Technologies Corp. is more attractive than Nutriband, Inc..
Company Buy Ratings Hold Ratings Sell Ratings NMTCNeuroOne Medical Technologies Corp.1 0 0 NTRBNutriband, Inc.1 0 0 -
Is NMTC or NTRB More Risky?
NeuroOne Medical Technologies Corp. has a beta of 0.703, which suggesting that the stock is 29.673% less volatile than S&P 500. In comparison Nutriband, Inc. has a beta of 1.907, suggesting its more volatile than the S&P 500 by 90.735%.
-
Which is a Better Dividend Stock NMTC or NTRB?
NeuroOne Medical Technologies Corp. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Nutriband, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. NeuroOne Medical Technologies Corp. pays -- of its earnings as a dividend. Nutriband, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios NMTC or NTRB?
NeuroOne Medical Technologies Corp. quarterly revenues are $1.7M, which are larger than Nutriband, Inc. quarterly revenues of $622.5K. NeuroOne Medical Technologies Corp.'s net income of -$1.5M is higher than Nutriband, Inc.'s net income of -$2M. Notably, NeuroOne Medical Technologies Corp.'s price-to-earnings ratio is -- while Nutriband, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for NeuroOne Medical Technologies Corp. is 2.45x versus 21.85x for Nutriband, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income NMTCNeuroOne Medical Technologies Corp.2.45x -- $1.7M -$1.5M NTRBNutriband, Inc.21.85x -- $622.5K -$2M
-
Which has Higher Returns NMTC or NVNO?
enVVeno Medical Corp. has a net margin of -88.5% compared to NeuroOne Medical Technologies Corp.'s net margin of --. NeuroOne Medical Technologies Corp.'s return on equity of -166.02% beat enVVeno Medical Corp.'s return on equity of -57.7%.
Company Gross Margin Earnings Per Share Invested Capital NMTCNeuroOne Medical Technologies Corp.53.94% -$0.03 $8.5M NVNOenVVeno Medical Corp.-- -$0.23 $30.2M -
What do Analysts Say About NMTC or NVNO?
NeuroOne Medical Technologies Corp. has a consensus price target of $2.23, signalling upside risk potential of 231.6%. On the other hand enVVeno Medical Corp. has an analysts' consensus of $12.50 which suggests that it could grow by 3121.65%. Given that enVVeno Medical Corp. has higher upside potential than NeuroOne Medical Technologies Corp., analysts believe enVVeno Medical Corp. is more attractive than NeuroOne Medical Technologies Corp..
Company Buy Ratings Hold Ratings Sell Ratings NMTCNeuroOne Medical Technologies Corp.1 0 0 NVNOenVVeno Medical Corp.0 1 0 -
Is NMTC or NVNO More Risky?
NeuroOne Medical Technologies Corp. has a beta of 0.703, which suggesting that the stock is 29.673% less volatile than S&P 500. In comparison enVVeno Medical Corp. has a beta of 1.063, suggesting its more volatile than the S&P 500 by 6.264%.
-
Which is a Better Dividend Stock NMTC or NVNO?
NeuroOne Medical Technologies Corp. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. enVVeno Medical Corp. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. NeuroOne Medical Technologies Corp. pays -- of its earnings as a dividend. enVVeno Medical Corp. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios NMTC or NVNO?
NeuroOne Medical Technologies Corp. quarterly revenues are $1.7M, which are larger than enVVeno Medical Corp. quarterly revenues of --. NeuroOne Medical Technologies Corp.'s net income of -$1.5M is higher than enVVeno Medical Corp.'s net income of -$4.5M. Notably, NeuroOne Medical Technologies Corp.'s price-to-earnings ratio is -- while enVVeno Medical Corp.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for NeuroOne Medical Technologies Corp. is 2.45x versus 473.07x for enVVeno Medical Corp.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income NMTCNeuroOne Medical Technologies Corp.2.45x -- $1.7M -$1.5M NVNOenVVeno Medical Corp.473.07x -- -- -$4.5M
-
Which has Higher Returns NMTC or PAHC?
Phibro Animal Health Corp. has a net margin of -88.5% compared to NeuroOne Medical Technologies Corp.'s net margin of 7.29%. NeuroOne Medical Technologies Corp.'s return on equity of -166.02% beat Phibro Animal Health Corp.'s return on equity of 24.77%.
Company Gross Margin Earnings Per Share Invested Capital NMTCNeuroOne Medical Technologies Corp.53.94% -$0.03 $8.5M PAHCPhibro Animal Health Corp.32.8% $0.65 $1.1B -
What do Analysts Say About NMTC or PAHC?
NeuroOne Medical Technologies Corp. has a consensus price target of $2.23, signalling upside risk potential of 231.6%. On the other hand Phibro Animal Health Corp. has an analysts' consensus of $43.00 which suggests that it could grow by 5.47%. Given that NeuroOne Medical Technologies Corp. has higher upside potential than Phibro Animal Health Corp., analysts believe NeuroOne Medical Technologies Corp. is more attractive than Phibro Animal Health Corp..
Company Buy Ratings Hold Ratings Sell Ratings NMTCNeuroOne Medical Technologies Corp.1 0 0 PAHCPhibro Animal Health Corp.0 2 0 -
Is NMTC or PAHC More Risky?
NeuroOne Medical Technologies Corp. has a beta of 0.703, which suggesting that the stock is 29.673% less volatile than S&P 500. In comparison Phibro Animal Health Corp. has a beta of 0.771, suggesting its less volatile than the S&P 500 by 22.868%.
-
Which is a Better Dividend Stock NMTC or PAHC?
NeuroOne Medical Technologies Corp. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Phibro Animal Health Corp. offers a yield of 1.18% to investors and pays a quarterly dividend of $0.12 per share. NeuroOne Medical Technologies Corp. pays -- of its earnings as a dividend. Phibro Animal Health Corp. pays out 40.46% of its earnings as a dividend. Phibro Animal Health Corp.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios NMTC or PAHC?
NeuroOne Medical Technologies Corp. quarterly revenues are $1.7M, which are smaller than Phibro Animal Health Corp. quarterly revenues of $363.9M. NeuroOne Medical Technologies Corp.'s net income of -$1.5M is lower than Phibro Animal Health Corp.'s net income of $26.5M. Notably, NeuroOne Medical Technologies Corp.'s price-to-earnings ratio is -- while Phibro Animal Health Corp.'s PE ratio is 24.51x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for NeuroOne Medical Technologies Corp. is 2.45x versus 1.19x for Phibro Animal Health Corp.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income NMTCNeuroOne Medical Technologies Corp.2.45x -- $1.7M -$1.5M PAHCPhibro Animal Health Corp.1.19x 24.51x $363.9M $26.5M
-
Which has Higher Returns NMTC or SINT?
SINTX Technologies, Inc. has a net margin of -88.5% compared to NeuroOne Medical Technologies Corp.'s net margin of -1701.44%. NeuroOne Medical Technologies Corp.'s return on equity of -166.02% beat SINTX Technologies, Inc.'s return on equity of -208.36%.
Company Gross Margin Earnings Per Share Invested Capital NMTCNeuroOne Medical Technologies Corp.53.94% -$0.03 $8.5M SINTSINTX Technologies, Inc.-31.73% -$3.46 $7.5M -
What do Analysts Say About NMTC or SINT?
NeuroOne Medical Technologies Corp. has a consensus price target of $2.23, signalling upside risk potential of 231.6%. On the other hand SINTX Technologies, Inc. has an analysts' consensus of $16.75 which suggests that it could grow by 336.2%. Given that SINTX Technologies, Inc. has higher upside potential than NeuroOne Medical Technologies Corp., analysts believe SINTX Technologies, Inc. is more attractive than NeuroOne Medical Technologies Corp..
Company Buy Ratings Hold Ratings Sell Ratings NMTCNeuroOne Medical Technologies Corp.1 0 0 SINTSINTX Technologies, Inc.2 0 0 -
Is NMTC or SINT More Risky?
NeuroOne Medical Technologies Corp. has a beta of 0.703, which suggesting that the stock is 29.673% less volatile than S&P 500. In comparison SINTX Technologies, Inc. has a beta of 0.633, suggesting its less volatile than the S&P 500 by 36.717%.
-
Which is a Better Dividend Stock NMTC or SINT?
NeuroOne Medical Technologies Corp. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. SINTX Technologies, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. NeuroOne Medical Technologies Corp. pays -- of its earnings as a dividend. SINTX Technologies, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios NMTC or SINT?
NeuroOne Medical Technologies Corp. quarterly revenues are $1.7M, which are larger than SINTX Technologies, Inc. quarterly revenues of $208K. NeuroOne Medical Technologies Corp.'s net income of -$1.5M is higher than SINTX Technologies, Inc.'s net income of -$3.5M. Notably, NeuroOne Medical Technologies Corp.'s price-to-earnings ratio is -- while SINTX Technologies, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for NeuroOne Medical Technologies Corp. is 2.45x versus 6.51x for SINTX Technologies, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income NMTCNeuroOne Medical Technologies Corp.2.45x -- $1.7M -$1.5M SINTSINTX Technologies, Inc.6.51x -- $208K -$3.5M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Google Vs NVIDIA Stock: Which Is Best?
Alphabet (NASDAQ:GOOGL) and NVIDIA (NASDAQ:NVIDIA) are two of the market’s…
How High Could NVIDIA Stock Go?
NVIDIA (NASDAQ:NVDA) has been one of the best stocks to…
Stock Ideas
Buy
52
Is NVDA Stock a Buy?
Market Cap: $4.5T
P/E Ratio: 62x
Buy
61
Is AAPL Stock a Buy?
Market Cap: $4.1T
P/E Ratio: 38x
Buy
63
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 40x
Alerts
Buy
54
SMX alert for Dec 5
SMX (Security Matters) Plc [SMX] is up 154.74% over the past day.
Sell
15
HOV alert for Dec 5
Hovnanian Enterprises, Inc. [HOV] is down 22.58% over the past day.
Buy
67
NUTX alert for Dec 5
Nutex Health, Inc. [NUTX] is up 18.9% over the past day.
